Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $36.06 USD
Change Today +0.33 / 0.92%
Volume 29.0M
PFE On Other Exchanges
Symbol
Exchange
New York
Xetra
Mexico
SIX Swiss Ex
Stockholm
London
Sao Paulo
Bogota
As of 8:04 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mace L. Rothenberg M.D.

Chief Medical Officer and Senior Vice President of Clinical Development & Medical Affairs - Oncology Business Unit, Pfizer Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 5 different industries.

----

Background*

Dr. Mace L. Rothenberg M.D. has been Chief Medical Officer and Senior Vice President of Clinical Development and Medical Affairs for Oncology Business Unit at Pfizer Inc. since January 2014 and October 2008 respectively. Dr. Rothenberg is responsible for overseeing clinical research and development activities and post-marketing evaluation and monitoring for all oncology products. He also coordinates evaluation of anticancer compounds that emerge from Pfizer's new Biotechnology ...

Read Full Background

Corporate Headquarters*

235 East 42nd Street
New York, New York 10017

United States

Phone: 212-733-2323
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Unknown/Other Education 1985
Vanderbilt University
MD 1982
NYU Elaine A. and Kenneth G. Langone Medical Center
BA 1978
The University of Pennsylvania

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PFE:US $36.06 USD +0.33

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Paul Bulcke B.E.Chief Executive Officer, Member of Executive Board, Director and Member of Chairman's & Corporate Governance Committee
Nestlé S.A.
SFr.5.7M
Alan George Lafley Chairman, Chief Executive Officer, President and Member of Proxy Committee
The Procter & Gamble Company
$6.4M
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
$1.5M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PFIZER INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.